These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 405430)

  • 41. Regulation of tyrosinase synthesis and its processing in the hair follicular melanocytes of the mouse during eumelanogenesis and phaeomelanogenesis.
    Burchill SA; Virden R; Thody AJ
    J Invest Dermatol; 1989 Aug; 93(2):236-40. PubMed ID: 2502579
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tyrosinase maturation and pigment expression in B16 melanoma: relation to theophylline treatment and intracellular cyclic AMP.
    White R; Hanson GC; Hu Funan
    J Cell Physiol; 1979 Jun; 99(3):441-50. PubMed ID: 222787
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tyrosinase activity in the sera of patients with malignant melanoma: method and specificity.
    Nishioka K; Romsdahl MM; Fritsche HA; McMurtrey MJ
    Int J Cancer; 1977 Nov; 20(5):689-93. PubMed ID: 411760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proper folding and endoplasmic reticulum to golgi transport of tyrosinase are induced by its substrates, DOPA and tyrosine.
    Halaban R; Cheng E; Svedine S; Aron R; Hebert DN
    J Biol Chem; 2001 Apr; 276(15):11933-8. PubMed ID: 11124258
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tyrosinase isoenzymes in mammalian melanocytes. 2. Differential activation by alpha-melanocyte-stimulating hormone.
    Valverde P; Garcia-Borron JC; Jimenez-Cervantes C; Solano F; Lozano JA
    Eur J Biochem; 1993 Oct; 217(2):541-8. PubMed ID: 7901010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tyrosinases of murine melanocytes with mutations at the albino locus.
    Halaban R; Moellmann G; Tamura A; Kwon BS; Kuklinska E; Pomerantz SH; Lerner AB
    Proc Natl Acad Sci U S A; 1988 Oct; 85(19):7241-5. PubMed ID: 3140237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitiliginous achromia with malignant melanoma. Tyrosinase activity and ultrastructural study of achromic and normal skin.
    Perrot H; Ortonne JP; Schmitt D
    Arch Dermatol Res (1975); 1977 Jan; 257(3):247-53. PubMed ID: 402121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The possible role of tyrosinase in malignant growth.
    Rubin DM; Rubin EJ
    Med Hypotheses; 1983 Apr; 10(4):469-71. PubMed ID: 6410161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mammalian tyrosinase. Structural and functional interraltionship of isozymes.
    Hearing VJ; Nicholson JM; Montague PM; Ekel TM; Tomecki KJ
    Biochim Biophys Acta; 1978 Feb; 522(2):327-39. PubMed ID: 414782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level.
    Naeyaert JM; Eller M; Gordon PR; Park HY; Gilchrest BA
    Br J Dermatol; 1991 Oct; 125(4):297-303. PubMed ID: 1720016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of tyrosinase levels in amelanotic and melanotic melanoma cell cultures by a competitive enzyme-linked immunoadsorbent assay and by immunotitration analysis.
    Fuller BB; Iman DS; Lunsford JB
    J Cell Physiol; 1988 Jan; 134(1):149-54. PubMed ID: 3121644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Syndecan-2 regulates melanin synthesis via protein kinase C βII-mediated tyrosinase activation.
    Jung H; Chung H; Chang SE; Choi S; Han IO; Kang DH; Oh ES
    Pigment Cell Melanoma Res; 2014 May; 27(3):387-97. PubMed ID: 24472179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inactivation of tyrosinase by dopa.
    Tomita Y; Hariu A; Mizuno C; Seiji M
    J Invest Dermatol; 1980 Nov; 75(5):379-82. PubMed ID: 6776205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tyrosinase activity in primary cell culture of amelanotic melanoma cells.
    Słomiński A; Scisłowski PW; Bomirski A
    Biosci Rep; 1983 Nov; 3(11):1027-34. PubMed ID: 6140964
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines.
    Dutkiewicz R; Albert DM; Levin LA
    Exp Eye Res; 2000 May; 70(5):563-9. PubMed ID: 10870514
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tyrosinase activity in human ocular malignant melanoma.
    Hayasaka S; Nakazawa M; Ishiguro S; Mizuno K
    Graefes Arch Clin Exp Ophthalmol; 1986; 224(3):310-2. PubMed ID: 3086185
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tyrosinase activity and isoenzyme distribution corresponding to growth and regression of melanoma in Sinclair miniature swine.
    Kovacs SA; Geekie KM; Oxenhandler RW; Agris PF
    J Natl Cancer Inst; 1981 Sep; 67(3):645-51. PubMed ID: 6792414
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin.
    Körner A; Pawelek J
    Science; 1982 Sep; 217(4565):1163-5. PubMed ID: 6810464
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tyrosinase activity and abundance in Cloudman melanoma cells.
    Halaban R; Pomerantz SH; Marshall S; Lerner AB
    Arch Biochem Biophys; 1984 Apr; 230(1):383-7. PubMed ID: 6201140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.